Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
Become a Member | Sign in
Home>News>This Article

Vapourtec Keeps it Cool with Patented Cooled Reactor System

Published: Tuesday, December 03, 2013
Last Updated: Tuesday, December 03, 2013
Bookmark and Share
The patented Cooled Reactor system, developed by Vapourtec and launched in 2010, is continuing to play a key role in major flow chemistry research breakthroughs.

Recently cited in an important research paper “Continuous flow-processing of organometallic reagents using an advanced peristaltic pumping system and the telescoped flow synthesis of (E/Z)-Tamoxifen” by the Group of Prof Steven V. Ley, Department of Chemistry, University of Cambridge (UK),  the system contributes to a more efficient manufacturing process for Breast Cancer drug Tamoxifen. 

The system, which offers the ability to run continuous cryogenic reaction conditions down to -70C without the need to use expensive chillers and external devices, is currently used in laboratories around the world in conjunction with Vapourtec’s industry leading E-Series and R-Series flow chemistry systems.

Andrew Mansfield of Vapourtec commented: “The Cooled Reactor system utilises a dry ice heat exchanger to generate a chilled gas supply that cools the reactor down to the required temperature.

“A total of 110 research laboratories across the globe are currently using our patented Cooled Reactor system to maintain temperature consistency during flow chemistry experiments.

“It’s a ground breaking addition to our existing R-Series and E-Series flow chemistry systems that, three years after its introduction, is contributing to some of the most exciting chemistry research developments,” added Andrew.  

Founded in 2003, Vapourtec is established as one of the leading global manufacturers of flow chemistry systems for a wide range of industries across the world including education and pharmaceuticals. The company currently employs 12 people in Bury St Edmunds (UK) and Kuala Lumpur (Malaysia) and has received over 100 citations within peer review publications, significantly more than anyone else in their market.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Drug May Prevent Life-Threatening Muscle Loss in Advanced Cancers
New data describes how an experimental drug can stop life-threatening muscle wasting (cachexia) associated with advanced cancers and restore muscle health.
Chemical Design Made Easier
Rice University scientists prepare elusive organocatalysts for drug and fine chemical synthesis.
Nanocarriers May Carry New Hope for Brain Cancer Therapy
Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.
Potential Persistent Tuberculosis Treatment
Researchers have discovered several first-in-class compounds that target hidden TB infections by attacking a critical process the bacteria use to survive in the hostile environment of the lungs.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.
Giant Molecules Inhibit Ebola Infection
European researchers have designed a "giant" molecule formed by thirteen fullerenes covered by carbohydrates which, by blocking this receptor, are able to inhibit the cell infection by an artificial ebola virus model.
First Therapy Appearing to Reverse Decline in Parkinson’s
An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson’s disease and Lewy body dementia in a small clinical trial, say researchers at Georgetown University Medical Center (GUMC).
Fighting Pain with Ketamine
Researchers at the Texas A&M Health Science Center are using ketamine, a drug that already exists as an anesthetic, to treat pain.
Possible New Treatment for Neurodegenerative Diseases Found
Researchers at the University of Liverpool have found that a well-established anti-epileptic drug could also be used as a treatment for neurodegenerative diseases.
Breast Cancer Drug Beats Superbug
Tamoxifen helps white blood cells clear multidrug-resistant bacteria in lab and mouse studies.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos